Home

In re Kubin argued before the Federal Circuit
On January 7, the Federal Circuit heard oral argument in In re Kubin, a case expected to have significant impact in the area of biotechnology patents. Kubin represents the PTO's post-KSR return to a stance previously rejected by the Federal Circuit in the landmark decision of In re Deuel. In Deuel, the court rejected the PTO position that the existence in the prior art of a purified protein, combined with routine cloning methods, renders obvious a claim to a nucleic acid encoding the protein.
Harry Shubin profiled in Forbes.
Harry Shubin and Brion Heaney will teach Chemical Patent Practice at George Mason University School of Law for the fifth straight year this spring semester.
Scott Major and MWZB secure a victory for Florists' Transworld Delivery, Inc. (FTD) in a proceeding under the Uniform Domain Name Dispute Resolution Policy to transfer the domain name ftdblog.com. See the decision here.